PEOPLE - UK's National Institute for Clinical Excellence makes appointments:
This article was originally published in Clinica
Executive Summary
The UK's National Institute for Clinical Excellence (NICE) has appointed the three executive directors that will head the reformed organisation, after it takes over the public health prevention roles of the outgoing Health Development Agency next year. Andrew Dillon, the institute's current chief executive, Professor Peter Littlejohns, NICE's clinical and public health director, and Andrea Sutcliffe, its planning and resources director, will head the new National Institute for Health and Clinical Excellence when it comes into being on April 1.
You may also be interested in...
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.
Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories
Virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo and Reckitt for use in OTC respiratory nasal sprays, is being adapted for use in the dry eye and allergy categories.